In addition, expression of this BCR-ABL oncoprotein transforms hematopoietic progenitor cells; in an animal model, this transformation event activated downstream signaling proteins that increase cell survival and proliferation, indicating the essential oncogenic role of BCR-ABL in CML cells [6]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.